PlainPharmaWatch

CMS Open Payments · Program Year 2024

Teva Pharmaceuticals USA, Inc.

Teva Pharmaceuticals USA, Inc. reported $67,444,804.70 in payments to 141,158 physicians and teaching hospitals across 148,378 transactions.

See the rankings → How this is sourced
$67.4M
Total payments
148,378
Transactions
141,158
Recipients
+$1.4M
General Payments vs PY2023

Teva Pharmaceuticals USA, Inc. reported $67,444,804.70 in payments to 141,158 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #40 of 1,925 reporting manufacturers (0.5% of all US industry payments), averaging $477.80 per recipient across 5 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the editorial team.

The verdict

Teva Pharmaceuticals USA, Inc. pairs top-5% payment volume with an unusually diversified payment pattern across a wide recipient base.

#40
of 1,925 companies
0.5%
of all US industry payments
0.0%
paid to its single top recipient
5
payment categories

Release-over-release change

General Payments changed from PY2023 to PY2024

Teva Pharmaceuticals USA, Inc.'s CMS-reported General Payments increased by $1.4M (+11.4%) from PY2023 to PY2024. The comparison uses the same CMS manufacturer-by-payment-category summary for both years and excludes research and ownership or investment records.

CMS source labels for this exact identifier: PY2022: TEVA PHARMACEUTICALS USA, INC.PY2023: TEVA PHARMACEUTICALS USA, INC.PY2024: Teva Pharmaceuticals USA, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$12.5MPY2024$13.9M
PY2023
$12,469,990.99
PY2024
$13,893,191.72

How Teva Pharmaceuticals USA, Inc. ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

Teva Pharmaceuticals USA, Inc.'s total vs. every reporting company

CMS Open Payments, Program Year 2024

$67,444,805 Top 2% higher than 98% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). Below this entry. $8,084–$25,112: 167 reporting companies (9%). Below this entry. $25,112–$78,003: 249 reporting companies (13%). Below this entry. $78,003–$242,294: 295 reporting companies (15%). Below this entry. $242,294–$752,621: 270 reporting companies (14%). Below this entry. $752,621–$2,337,813: 263 reporting companies (14%). Below this entry. $2,337,813–$7,261,783: 200 reporting companies (10%). Below this entry. $7,261,783–$22,556,757: 133 reporting companies (7%). Below this entry. $22,556,757–$70,066,439: 45 reporting companies (2%). This entry sits in this band. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for Teva Pharmaceuticals USA, Inc.

Averaging $454.55 per transaction and $477.80 per recipient, Teva Pharmaceuticals USA, Inc.'s Program Year 2024 total comes to $67,444,804.70 across 148,378 transactions and 141,158 physicians and teaching hospitals. In the CMS Open Payments database that is good for rank #40 of 1,925 companies, representing 0.5% of all industry payments reported nationwide for the year.

"Compensation for Services Other Than Consulting" leads the 5-category general-payment breakdown below at $8.4M (12.4% of the company's reported total, 3,553 transactions) - see our methodology for how research and ownership payments are reported separately.

General Payment Breakdown by Type

"Compensation for Services Other Than Consulting" leads Teva Pharmaceuticals USA, Inc.'s 5-category general-payment breakdown at $8.4M, 12.4% of the reported total.

How Teva Pharmaceuticals USA, Inc. divides its payments

Ranked by total dollars reported per category

1. Compensation for Services…$8.4M2. Food and Beverage$3.2M3. Travel and Lodging$1.1M4. Consulting Fee$906.0K5. Education$236.9K
Payment Type Amount Transactions
Compensation for Services Other Than Consulting $8.4M 3,553
Food and Beverage $3.2M 130,574
Travel and Lodging $1.1M 4,382
Consulting Fee $906.0K 229
Education $236.9K 2,420

Recipient Concentration in General Payments

The five largest recipient relationships account for $940,327.26 (6.8%) of $13,893,191.72 in this company's General Payments records across 30,317 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Teva Pharmaceuticals USA, Inc.

The five named recipients with the highest reported General Payments from this company

Leslie Citrome$208.9KAmber Renee Hoberg$208.2KGustavo Alva$182.8KRakesh Jain$174.6KAmita Patel$165.8K
  1. 1

    Leslie Citrome

    $208,922.63 across 186 reported transactions

  2. 2

    Amber Renee Hoberg

    $208,191.77 across 326 reported transactions

  3. 3

    Gustavo Alva

    $182,808.65 across 173 reported transactions

  4. 4

    Rakesh Jain

    $174,580.46 across 169 reported transactions

  5. 5

    Amita Patel

    $165,823.75 across 170 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $454.55. Average per recipient: $477.80.

Total Amount

$67,444,804.70

Avg per Transaction

$454.55

Avg per Recipient

$477.80

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

Teva Pharmaceuticals USA, Inc. Share

0.5%

#40 by total payments

Companies with Similar Payment Volumes

Pharmaceutical companies with payment totals similar to Teva Pharmaceuticals USA, Inc.

Advanced Accelerator Applications

$63.9M 167 recipients

Gilead Sciences, Inc.

$72.7M 118,932 recipients

Intuitive Surgical, Inc.

$74.7M 126,596 recipients

Biogen, Inc.

$59.9M 36,001 recipients

Innovation Technologies Inc

$75.8M 3,361 recipients

Bayer Healthcare Pharmaceuticals Inc.

$58.0M 146,928 recipients

Frequently Asked Questions

How much did Teva Pharmaceuticals USA, Inc. pay to physicians and hospitals in 2024? ▾
Teva Pharmaceuticals USA, Inc. made $67,444,804.70 in payments to physicians and hospitals in Program Year 2024, across 148,378 individual transactions. This represents 0.5% of all industry payments reported to CMS Open Payments.
How many physicians received payments from Teva Pharmaceuticals USA, Inc.? ▾
141,158 physicians and teaching hospitals received payments from Teva Pharmaceuticals USA, Inc. in 2024, averaging $477.80 per recipient.
What types of payments did Teva Pharmaceuticals USA, Inc. make? ▾
General payments from Teva Pharmaceuticals USA, Inc. span 5 distinct categories, covering things like consulting, meals, and travel. The largest general-payment category was "Compensation for Services Other Than Consulting" at $8.4M, representing 12.4% of the company's reported total.
How does Teva Pharmaceuticals USA, Inc. rank among pharmaceutical companies? ▾
By total payment amount, Teva Pharmaceuticals USA, Inc. sits at #40 of 1,925 companies in the CMS Open Payments database for 2024.
What is the average payment size from Teva Pharmaceuticals USA, Inc.? ▾
Teva Pharmaceuticals USA, Inc.'s 148,378 transactions to 141,158 recipients in 2024 averaged $454.55 per transaction.
Where does the payment data for Teva Pharmaceuticals USA, Inc. come from? ▾
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Teva Pharmaceuticals USA, Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.